Skip to main content

Day: November 10, 2025

Salem Media Group has Released its Third Quarter 2025 Quarterly Report

CAMARILLO, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — Salem Media Group, Inc. (OTCQX: SALM) announced today its third quarter 2025 Quarterly Report has been posted on its investor relations website. About Salem Media GroupSalem Media Group is America’s premier multimedia company specializing in Christian and conservative content. Through its national radio network, digital platforms, and publishing brands, Salem reaches millions daily with powerful content that drives the national conversation. Learn more at salemmedia.com. Company Contact:Sara BroadwaterPublicity@salemmedia.com

Continue reading

Voxtur Analytics Corp. Initiates Court-Supervised Restructuring Process to Strengthen Financial Position and Support Long-Term Growth

TORONTO and TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTC PINK: VXTRF) (“Voxtur” or the “Company”), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today announced that the Company and certain subsidiaries and affiliates, iLOOKABOUT (US) Inc., iLOOKABOUT Inc., MTAG Paralegal Professional Corporation, Voxtur Settlement Services, LLC, Appraisers Now Ltd., Voxtur Analytics US Corp., Appraisers Now US, LLC, Blue Water Financial Technologies Holding Company, LLC, Blue Water Financial Technologies, LLC, Blue Water Financial Technologies Services, LLC, Municipal Tax Equity Consultants Inc., MTE Paralegal Professional Corporation, Commonwealth USA Settlements, LLC, Voxtur Settlement Services of Alabama, LLC, Voxtur...

Continue reading

IMUNON Public Webcast Highlights Resilience and Innovation in Pursuit of the First Approved Immunotherapy for Ovarian Cancer

Webcast Recording and Symposium Slides Now Available LAWRENCEVILLE, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today hosted a compelling public webcast, where cancer key opinion leaders, principal investigators from the Phase 3 OVATION 3 and Phase 2 minimal residual disease (MRD) trials, clinicians, statistical experts and IMUNON executives shared critical insights into the disease and translational data, along with compelling clinical data highlighting the significant potential of IMNN-001 for women with advanced ovarian cancer. A webcast of the live event and presentation materials are available on the “Scientific Presentations” page of the IMUNON website at https://investors.imunon.com/scientific-presentations. About IMUNON IMUNON...

Continue reading

EuroDry Ltd. Sets Date for the Release of Third Quarter 2025 Results, Conference Call and Webcast

ATHENS, Greece, Nov. 10, 2025 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that it will release its financial results for the third quarter ended September 30, 2025, on November 13, 2025 before market opens in New York. On the same day, Thursday, November 13, 2025, at 11:30 a.m. Eastern Time, the Company’s management will host a conference call and webcast to discuss the results. Conference Call details:Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 877 405 1226 (US Toll-Free Dial In) or +1 201 689 7823 (US and Standard International Dial In). Please quote “EuroDry” to the operator and/or conference ID 13757175. Click...

Continue reading

Rakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting

VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that new data will be presented in two posters at the Society for Neuro-Oncology (SNO) Annual Meeting, taking place November 19–23, 2025, in Honolulu, Hawaii. The presentations will highlight Rakovina’s AI-driven programs to discover and develop next-generation DNA-damage response (DDR) inhibitors engineered for central nervous system (CNS) penetration, supporting the development of potential new treatment options for primary and metastatic brain cancers. Presentation Details: Title: Discovery and development of a novel CNS-penetrating ATR inhibitorSession: Poster Session – DNA Repair...

Continue reading

Chenghe Acquisition III Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on November 11, 2025

Singapore, Nov. 10, 2025 (GLOBE NEWSWIRE) — Chenghe Acquisition III Co. (the “Company”) today announced that, commencing on November 11, 2025, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A Ordinary Shares (the “Shares”) and warrants (the “Warrants”) included in the Units. The Shares and Warrants received from the separated Units will trade on the Nasdaq Global Market (“Nasdaq”) under the symbols “CHEC” and “CHECW”, respectively. Units that are not separated will continue to trade on Nasdaq under the symbol “CHECU”. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need to have their brokers contact Odyssey Stock Transfer & Trust Company, the Company’s transfer agent,...

Continue reading

Crown Reserve Acquisition Corp. I Announces the Closing of $172,500,000 Initial Public Offering

Grand Cayman, Cayman Islands, Nov. 10, 2025 (GLOBE NEWSWIRE) — Crown Reserve Acquisition Corp. I (the “Company”) (Nasdaq: CRACU) announced today the closing of its initial public offering of 17,250,000 units at a price of $10.00 per unit, including 2,250,000 units sold pursuant to the full exercise of the underwriter’s over-allotment option. The offering resulted in gross proceeds of $172,500,000. The units began trading on the Nasdaq Global Market (“Nasdaq”) on November 7, 2025, under the ticker symbol “CRACU.” Each unit consists of one Class A ordinary share, one-half of one redeemable warrant, and one right (the “Share Right”) to receive one-fifth (1/5) of one Class A ordinary share upon the consummation of an initial business combination. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share...

Continue reading

APPROVAL OF THE REVISION OF THE VOLUNTARY SHARE EXCHANGE TENDER OFFER MADE BY EURONEXT N.V. (“OFFEROR” OR “EURONEXT”) FOR THE ORDINARY REGISTERED SHARES OF HELLENIC EXCHANGES-ATHENS STOCK EXCHANGE S.A. (“ATHEX”)

ANNOUNCEMENT APPROVAL OF THE REVISION OF THE VOLUNTARY SHARE EXCHANGE TENDER OFFER MADE BY EURONEXT N.V. (“OFFEROR” OR “EURONEXT”) FOR THE ORDINARY REGISTERED SHARES OF HELLENIC EXCHANGES-ATHENS STOCK EXCHANGE S.A. (“ATHEX”) TENDER OFFER REVISIONOn 7 November 2025, (the “Date of the Revision”), Euronext announced that in accordance with Article 21, paragraph 2 of Law 3461/2006 (the “Law”), it has submitted to the Hellenic Capital Market Commission (the “HCMC”) a request to revise the voluntary tender offer (the “Tender Offer”) that the Offeror had submitted on 30 July 2025 (the “Date of the Tender Offer”) aiming to acquire all ordinary registered shares, each having a nominal value of €0.42 (each, a “ATHEX Share”) issued by ATHEX, which Euronext and any “persons acting in concert” (as defined in article 2(e) of the Law) with Euronext,...

Continue reading

DRYWORLD Partners with EPIC as Official Apparel Supplier for the World’s Premier Amateur Pickleball Championship

Strategic Alliance to Outfit Global Athletes and Fans, Fueling the Explosive Growth of Pickleball with Premium Performance Gear SINGAPORE and SANTA BARBARA, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — DRYWORLD Brands Inc. (IBGR), a leading performance apparel and athletic footwear brand, today announced a groundbreaking multi-year partnership with EPIC (Elite Pickleball International Championship PTE LTD), appointing DRYWORLD as the Official Fashion, Technical, and Apparel Partner. This exclusive collaboration will provide co-branded apparel, footwear, accessories, and fanwear to EPIC’s World Championship players, staff, and global community, while launching a dedicated e-commerce line to capitalize on pickleball’s meteoric rise as the world’s fastest-growing sport. EPIC, the pinnacle of amateur pickleball, is set...

Continue reading

Rexel: Disclosure of trading in own shares from Nov. 3 to Nov. 7, 2025

RELEASE                   DISCLOSURE OF TRADING IN OWN SHARES FROM NOVEMBER 3 TO NOVEMBER 7, 2025 In accordance with the authorization granted by the Shareholders’ Meeting in order to trade in own shares and pursuant to applicable law on share repurchases, Rexel declares the following purchases of its own shares from November 3 to November 7, 2025:Name of the issuer Identity code of the issuer (Legal Entity Identifier) Day of transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code)REXEL 969500N6AVPA51648T62 03/11/2025 FR0010451203 39 000 30,0862 XPARREXEL 969500N6AVPA51648T62 04/11/2025 FR0010451203 53 765 29,382 XPARREXEL 969500N6AVPA51648T62 05/11/2025 FR0010451203 37 901 29,4661 XPARREXEL 969500N6AVPA51648T62 06/11/2025 FR0010451203 ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.